KARMIEL, Israel & LONDON--(BUSINESS WIRE)--Medgenics (AIM:MEDG), the US incorporated holding company of a biopharmaceutical group, is pleased to announce that the Company’s issued shares of common stock of par value of US $0.0001 each (“Common Shares”) have been admitted to trading on AIM, and dealings in the Common Shares of the Company will start at 8.00am today, 4 December 2007. The Admission to AIM follows the Company’s successful fund raising which raised a total of £3.276 million.
